BSEBoard Meeting1d ago · 30 Oct 2026, 03:09 pm

Tavexia Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting

Tavexia Lifecare Ltd · 539519

✦ AI SummaryResults

Tavexia Lifecare Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 04/11/2026 to consider and approve unaudited financial results for the quarter and half-year ended September 30, 2026, along with the Limited Review Report of the Statutory Auditors, change of Registrar and Share Transfer Agent, and initial proposal for fund raising.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk3/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Tavexia Lifecare Ltd - 539519 - Board Meeting Intimation for Board Meeting

Attachments (1)

📄

125f1aa0-aa6d-4c02-9723-f7442764681d.pdf

pdf

Download →
View document text
TAVEXIA LIFECARE LIMITED (FORMERLY SATTVA SUKUN LIFECARE LIMITED) CIN: L27509MH1980PLC329224 Date: 30/10/2026 The Department of Corporate Services BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400001. Scrip Code: 539519 Subject: Prior Intimation of Board Meeting pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of Tavexia Lifecare Limited (formerly known as Sattva Sukun Lifecare Limited) is scheduled to be held on Wednesday 4th November, 2026, inter alia, to consider and transact the following business: 1. To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half-year ended September 30, 2026, along with the Limited Review Report of the Statutory Auditors thereon. 2. To consider and approve the change of Registrar and Share Transfer Agent (RTA) of the Company and to take necessary steps in this regard, subject to applicable regulatory and other approvals, wherever required. 3. To Discuss and approve the initial proposal for fund raising by issue and allotment of Securities of the company (Equity/Warrants) through Preferential Issue/ Right Issue or other mode ; 4. To consider and discuss any other matter with the permission of the Chair. Further, in accordance with the Company's Code of Conduct for Prevention of Insider Trading, the trading window for dealing in the securities of the Company shall remain closed for all designated persons and their immediate relatives until 48 hours after the declaration of the financial results for the quarter and half-year ended September 30, 2026. You are requested to take the above information on record. Thanking you, For Tavexia Lifecare Limited Poonam Rani Company Secretary Regd. Office: Plot No. 2B/1, Ground Floor, Kandivali Cooperative Industrial Estate Ltd., Hindustan Naka, Kandivali (West), Mumbai – 400067 Tel: +91-22-2868 4491 | Email: info@mayukh.co.in & sattvasukunlifecarelimited@gmail.com| Website: www.mayukh.co.in & https://sattvasukun.co.in/